- Issuer
- GraniteShares
- Inception Date
- May 4, 2026
- Category
- Derivative Income
- Leveraged
- 1x (No leverage)
- Index Tracked
- No Index (Active)
- Distribution Policy
- Distributing
- Asset Class
- Equity
Share Price Chart
Loading charts...
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Performance
BIOY Performance Chart
Loading charts...
Returns By Period
GraniteShares YieldBOOST Biotech ETF
- 1D
- 0.04%
- 1M
- 0.80%
- YTD
- —
- 6M
- —
- 1Y
- —
- 3Y*
- —
- 5Y*
- —
- 10Y*
- —
Benchmark (S&P 500 Index)
- 1D
- 1.18%
- 1M
- -1.84%
- YTD
- 8.69%
- 6M
- 7.74%
- 1Y
- 20.53%
- 3Y*
- 18.69%
- 5Y*
- 11.60%
- 10Y*
- 13.47%
BIOY Monthly Returns History
Based on dividend-adjusted daily data since May 5, 2026, BIOY's average daily return is +0.02%, while the average monthly return is +0.34%. At this rate, an investment would double in approximately 17.0 years.
Historically, 50% of months were positive and 50% were negative. The best month was Jun 2026 with a return of +0.8%, while the worst month was May 2026 at -0.1%. The longest winning streak lasted 1 consecutive months, and the longest losing streak was 1 months.
On a daily basis, BIOY closed higher 74% of trading days. The best single day was Jun 4, 2026 with a return of +1.9%, while the worst single day was Jun 5, 2026 at -2.8%.
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Total | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | -0.11% | 0.80% | 0.69% |
Expense Ratio
BIOY has a high expense ratio of 1.07%, indicating above-average management fees.
Return for Risk
Return / Risk — by metrics
The table below present risk-adjusted performance metrics for GraniteShares YieldBOOST Biotech ETF (BIOY) and compare them to S&P 500 Index.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| BIOY | Benchmark | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | — | — | |
| Sortino ratioReturn per unit of downside risk | — | — | |
| Omega ratioGain probability vs. loss probability | — | 1.30 | — |
| Calmar ratioReturn relative to maximum drawdown | — | 2.27 | — |
| Martin ratioReturn relative to average drawdown | — | 9.90 | — |
Dividends
Dividend History
GraniteShares YieldBOOST Biotech ETF provided a 9.48% dividend yield over the last twelve months, with an annual payout of $2.19 per share.
| Period | TTM |
|---|---|
| Dividend | $2.19 |
Dividend yield | 9.48% |
Monthly Dividends
The table displays the monthly dividend distributions for GraniteShares YieldBOOST Biotech ETF. The dividends shown in the table have been adjusted to account for any splits that may have occurred.
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Total | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | $1.12 | $1.07 | $2.19 |
Drawdowns
Drawdowns Chart
The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.
Loading charts...
Worst Drawdowns
The table below displays the maximum drawdowns of the GraniteShares YieldBOOST Biotech ETF. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.
The maximum drawdown for the GraniteShares YieldBOOST Biotech ETF was 5.07%, occurring on Jun 8, 2026. The portfolio has not yet recovered.
The current GraniteShares YieldBOOST Biotech ETF drawdown is 0.76%.
Related event | Drawdown | Fall | Recovery | Underwater |
|---|---|---|---|---|
2026 pullback2026 | -5.07%Jun 2026 | 24d | — | 1mo 16dMay 2026 - now |
2026 pullback2026 | -0.69%May 2026 | 0s | 4d | 4dMay 2026 - May 2026 |
2026 pullback2026 | -0.37%May 2026 | 0s | 1d | 1dMay 2026 - May 2026 |
Drawdown Indicators
| BIOY | Benchmark | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -5.07% | -56.78% | +51.71% |
Max Drawdown (1Y)Largest decline over 1 year | — | -9.10% | — |
Max Drawdown (3Y)Largest decline over 3 years | — | -18.90% | — |
Max Drawdown (5Y)Largest decline over 5 years | — | -25.43% | — |
Max Drawdown (10Y)Largest decline over 10 years | — | -33.92% | — |
Current DrawdownCurrent decline from peak | -0.76% | -2.23% | +1.47% |
Average DrawdownAverage peak-to-trough decline | -2.21% | -10.71% | +8.50% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | — | 2.08% | — |
Volatility
Volatility Chart
The chart below shows the rolling one-month volatility.
Loading charts...
Build a portfolio with BIOY
Add GraniteShares YieldBOOST Biotech ETF to a portfolio and analyze allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Analyzer with BIOY